We are live on ! Find out more
LPCN icon

Lipocine
LPCN

33 hedge funds and large institutions have $5.42M invested in Lipocine in 2020 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,223% more call options, than puts

Call options by funds: $172K | Put options by funds: $13K

231% more capital invested

Capital invested by funds: $1.64M → $5.42M (+$3.79M)

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

100% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 5

18% more funds holding

Funds holding: 28 → 33 (+5)

0.08% more ownership

Funds ownership: 0.45% → 0.53% (+0.08%)

Holders
33
Holders Change
+5
Holders Change %
+17.86%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
7
Reduced
3
Closed
5
Calls
$172K
Puts
$13K
Net Calls
+$159K
Net Calls Change
+$152K

Top Buyers

1
BBVA
Banco Bilbao Vizcaya Argentaria
Spain
+$152K
2
Mercer Global Advisors
Mercer Global Advisors
Colorado
+$116K
3
Two Sigma Investments
Two Sigma Investments
New York
+$73.9K
4
GCP
GSA Capital Partners
United Kingdom
+$46K
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$42.1K

Top Sellers

1
BlackRock
BlackRock
New York
-$62.8K
2
FPCG
Fort Pitt Capital Group
Pennsylvania
-$25K
3
Citadel Advisors
Citadel Advisors
Florida
-$9.34K
4
PAG
Private Advisor Group
New Jersey
-$5K
5
UBS Group
UBS Group
Switzerland
-$1.74K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.39M +$28.9K +2,229 +4%
Ameriprise
2
Ameriprise
Minnesota
$994K -$1.17K -90 -0.2%
BlackRock
3
BlackRock
New York
$911K -$62.8K -4,844 -10%
Renaissance Technologies
4
Renaissance Technologies
New York
$398K +$31.2K +2,411 +15%
Mercer Global Advisors
5
Mercer Global Advisors
Colorado
$343K +$116K +8,922 +126%
BBVA
6
Banco Bilbao Vizcaya Argentaria
Spain
$252K +$152K +11,765 New
Geode Capital Management
7
Geode Capital Management
Massachusetts
$251K – – –
Two Sigma Investments
8
Two Sigma Investments
New York
$122K +$73.9K +5,700 New
CL
9
Choreo LLC
Illinois
$82K – – –
Millennium Management
10
Millennium Management
New York
$79K +$4.87K +376 +11%
GCP
11
GSA Capital Partners
United Kingdom
$76K +$46K +3,551 New
Northern Trust
12
Northern Trust
Illinois
$72K +$5.74K +443 +15%
Qube Research & Technologies (QRT)
13
Qube Research & Technologies (QRT)
United Kingdom
$70K +$42.1K +3,252 New
California Public Employees Retirement System
14
California Public Employees Retirement System
California
$58K – – –
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$58K +$26.9K +2,078 +319%
LPL Financial
16
LPL Financial
California
$53K +$32.2K +2,485 New
Group One Trading
17
Group One Trading
Illinois
$47K +$3.67K +283 +15%
TRCT
18
Tower Research Capital (TRC)
New York
$26K +$15.7K +1,214 New
Goldman Sachs
19
Goldman Sachs
New York
$26K +$15.9K +1,227 New
Two Sigma Advisers
20
Two Sigma Advisers
New York
$23K +$14.1K +1,088 New
SM
21
Sabby Management
Florida
$18K +$11K +850 New
Osaic Holdings
22
Osaic Holdings
Arizona
$17K – – –
CG
23
Cutler Group
California
$16K – – –
State Street
24
State Street
Massachusetts
$16K – – –
Barclays
25
Barclays
United Kingdom
$10K +$5.95K +459 New
1
2

LPCN Hedge Fund Activity: Q2 2020 in Review

33 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Lipocine (LPCN) for Q2 2020, worth a combined $5.42M — up 231% from $1.64M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new LPCN positions and 5 closed out — a net gain of 5 holders — while 7 added to existing stakes and 3 trimmed.

The largest buyer was Banco Bilbao Vizcaya Argentaria, opening a new position worth an estimated $152K. The largest seller was BlackRock, cutting an estimated $62.8K.

  • 33 institutional investors held Lipocine (LPCN) as of Q2 2020, up from 28 in Q1 2020.
  • Funds reported $5.42M of Lipocine stock for Q2 2020, up 231% quarter-over-quarter.
  • 10 funds opened new Lipocine positions in Q2 2020 and 5 closed out, a net change of +5 holders.
  • The largest Lipocine buyer in Q2 2020 was Banco Bilbao Vizcaya Argentaria, an estimated $152K added.
  • The largest Lipocine seller in Q2 2020 was BlackRock, an estimated $62.8K sold.

Based on aggregated 13F filings for Q2 2020.